Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025 (U.S. market close). Destiny Tech100 Inc. (NYSE: DXYZ) just posted a sharp, high-volume run-up as investor attention snapped back to one theme: SpaceX IPO speculation—and what it could mean for public-market “access” vehicles tied to private tech leaders. But DXYZ isn’t a conventional operating company stock. It’s a closed-end management investment company built to hold a portfolio of late-stage private tech names, and it can trade far away from the value of its underlying assets (NAV). Destiny+1 Below is a detailed, publication-ready breakdown of this week’s move (Dec. 8–12), the most important news from the last
Altria (MO) Stock This Week: CEO Succession, Dividend Update, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Altria (MO) Stock This Week: CEO Succession, Dividend Update, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (after market close) Altria Group, Inc. (NYSE: MO) ended the week on a quiet but steady note—closing at $58.75 on Friday, Dec. 12, extending a five-session grind higher from $58.11 on Dec. 8 (about +1.1% for the week). Investing.comWhile the broader market sold off on Friday, Altria’s shares were essentially unchanged on the day—an example of why income-focused investors often treat the tobacco giant as a defensive holding. MarketWatch+1 But “quiet price action” doesn’t mean “no catalysts.” Two company headlines landed back-to-back in the last few days—a leadership succession plan and a fresh dividend declaration—and they
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) Milestone Pharmaceuticals Inc. (NASDAQ: MIST) closed out the week in the spotlight after the company announced U.S. FDA approval of CARDAMYST™ (etripamil)—positioning Milestone to transition from a development-stage biotech to a commercial-stage cardiovascular company. GlobeNewswire+1 The stock action was anything but calm. MIST closed at $2.41 on Dec. 12, down 18.31%, after swinging through a wide intraday range and printing exceptionally heavy volume. After-hours trading showed a modest rebound. StockAnalysis Below is a detailed breakdown of the latest Milestone Pharmaceuticals news, this week’s trading story, forecasts and analyst targets, and the week-ahead
MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)Meta description: MercadoLibre (MELI) ended the week near $2,016 after a volatile stretch that included a 5% midweek drop, a new humanoid-robot warehouse pilot, and a $750 million bond deal. Here’s what moved the stock this week and what investors are watching next week. MercadoLibre, Inc. (NASDAQ: MELI) closed Friday, Dec. 12, 2025 at $2,015.89, finishing a choppy week that featured a sharp selloff on Wednesday and a rebound attempt into the close. StockAnalysis The headline catalyst in the final days of the week wasn’t earnings—it was automation and capital markets. MercadoLibre announced a
AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Inc. (NYSE: ABBV) ended the week of Dec. 8–12, 2025 near $223, after a choppy stretch that featured two notable Wall Street moves—an HSBC upgrade and a Morgan Stanley price-target hike—alongside ongoing headlines tied to AbbVie’s oncology and neuroscience pipeline. Yahoo Finance+2MarketBeat+2 For investors, the near-term story remains a familiar one: ABBV’s share price is being pulled between defensive-dividend appeal (especially in an uncertain macro backdrop) and the market’s ongoing debate over how durable AbbVie’s post-Humira growth engine will be—driven mainly by Skyrizi and Rinvoq, plus a deepening pipeline. AbbVie News Center+1 ABBV stock this week: Where AbbVie shares
Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (NYSE: MPW) ended the week near $5.10 after a sharp Thursday drop. Here’s what moved MPW stock this week, the latest tenant and legal headlines, analyst forecasts, and the key catalysts to watch in the week ahead. Medical Properties Trust, Inc. (NYSE: MPW) finished the Dec. 8–12 trading week under renewed pressure, closing Friday around $5.10 after a volatile stretch that included a sharp selloff on Thursday. Finviz For investors, MPW remains a story of two forces pulling in opposite directions: Below is a full “this week / week ahead” briefing—written for readers tracking MPW stock day
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) closed at $81.65 on Dec. 12 after a headline-heavy week featuring new Google Cloud and Meta agreements, raised 2025–2026 EPS guidance, and fresh analyst price targets. NextEra Energy, Inc. (NYSE: NEE) ended Friday, Dec. 12, 2025, at $81.65. Yahoo Finance That close caps a volatile, news-packed week in which the company leaned hard into a single message for investors: power demand is accelerating, and the fastest-growing customers are increasingly AI and data-center developers—a trend NextEra believes can translate into multi-year earnings and dividend growth. NextEra Energy Investor Relations+1 Below is a complete, publication-ready breakdown of what moved
Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Updated: Friday, December 12, 2025 (U.S. market close)Company: The Coca-Cola Company (NYSE: KO) Coca-Cola stock ended the week near the $70 level after a choppy stretch of trading that included a sharp one-day dip and a strong Friday rebound. Investors are weighing a leadership transition set for 2026, the company’s steady “defensive” profile, and the next set of catalysts: a dividend payment on Monday (Dec. 15) and a data-heavy U.S. economic calendar that could influence interest rates—and by extension the appeal of dividend-focused stocks like KO. StockAnalysis+2StockAnalysis+2 KO stock recap: what happened this week (Dec. 8–Dec. 12) Coca-Cola shares closed
Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income Corporation (NYSE: O) closed this week with investors balancing two fresh, shareholder-friendly headlines—a new dividend increase and a headline-grabbing $800 million preferred equity investment in CityCenter Las Vegas—against the bigger force that still tends to steer net-lease REITs: interest rates and bond yields. StockAnalysis Below is what moved Realty Income stock this week, what the latest announcements mean for income-focused investors, and what to watch in the week ahead as markets digest the Fed’s latest move and year-end positioning ramps up. Realty Income stock this week: a choppy slide despite positive company news Realty Income ended Friday, Dec.
DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

Updated: December 12, 2025 — DoorDash, Inc. (NASDAQ: DASH) ended Friday at $227.49, up 1.32% on the day, with a market value of roughly $99.6 billion. FinanceCharts+1 It was a volatile week for DoorDash stock: shares slid hard midweek as investors repriced the competitive outlook in online grocery and “instant” delivery, then stabilized as attention turned back to DoorDash’s scale, expansion strategy, and a fresh round of analyst updates. Investing.com+2Barron’s+2 Below is a comprehensive, publication-ready look at what moved DoorDash stock this week, the latest DoorDash news, and the key catalysts for the week ahead (Dec. 15–19). DoorDash stock price
Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Updated: December 12, 2025 Altria Group, Inc. (NYSE: MO) ended Friday, Dec. 12, at $58.75, extending a string of modest daily gains and leaving the stock up roughly ~1%–1.3% over the last five sessions—a steady week for a high-yield, defensive name as investors digested two company-specific headlines: a CEO succession announcement and a fresh quarterly dividend declaration. StockAnalysis+2Reuters+2 With the market increasingly sensitive to interest rates and yield-based positioning, Altria’s “bond proxy” characteristics (plus its dividend that remains among the richer payouts in large-cap U.S. equities) keep MO on the watchlist for income-focused investors heading into the final full trading
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Nike, Inc. (NYSE: NKE) heads into next week with its biggest near-term catalyst on the calendar: fiscal Q2 2026 earnings on Thursday, Dec. 18 (after the close). Nike Investor Relations After a volatile start to the week, Nike shares finished Friday at $67.47 (down 0.40% on the day) and ended the week up about 2.4% versus last Friday’s close. StockAnalysis The setup now is a familiar one for investors: a globally dominant brand in the middle of a turnaround (“Win Now”), facing tariff-driven cost pressure, digital and direct-to-consumer (DTC) traffic questions, and intensifying

Stock Market Today

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

7 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, after surging 6.1% the previous day on stronger FY2025 profit and a larger dividend plan. The company bought back 151,400 shares for about S$1.74 million. Keppel reported a 29% rise in full-year profit to S$1.02 billion and proposed a total distribution of 47 cents per share, including a special dividend partly paid in Keppel REIT units.
ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop